Chronic Lung Disease and <= 24 Months of Age or
1 clinical trials · Condition
◉ Watch Chronic Lung Disease and <= 24 Months of Age or
| Record | Firm | Date |
|---|---|---|
| Study of Motavizumab (MEDI-524) and Palivizumab Administered Sequentially in the Same Respiratory Syncytial Virus (RSV) Season (NCT00316264) | MedImmune LLC | 2006-04-01 |
Track Chronic Lung Disease and <= 24 Months of Age or automatically
Every clearance here is in the API, with alerts when new ones post.